Disease characteristics of diffuse large B‐cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience-Reference-Cited by-同舟云学术

Disease characteristics of diffuse large B‐cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience

Published:2019-12-03 Issue:1 Volume:38 Page:38-50
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Gaut Daria¹^ORCID,Romero Tahmineh²,Oveisi David¹,Howell Grant³,Schiller Gary⁴

Affiliation:

1. Deparment of Medicine, David Geffen School of MedicineUniversity of California Los Angeles Los Angeles California USA

2. Division of General Internal Medicine and Health Services Research, Department of Medicine Statistics Core, David Geffen School of MedicineUniversity of California Los Angeles Los Angeles California USA

3. David Geffen School of MedicineUniversity of California Los Angeles Los Angeles California USA

4. Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles Los Angeles California USA

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2690

Reference45 articles.

1. Management of relapsed-refractory diffuse large B cell lymphoma

2. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

3. Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

4. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up

5. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review;Frontiers in Immunology;2023-01-17